Versartis Inc.: Clinical Trials

8 trials sponsored by Versartis Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 4 terminated. 5 Phase 2, 4 Phase 3, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Terminated 3, Completed 2
Phase 34Terminated 3, Completed 1
Phase 12Completed 2

Follow Versartis Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Long-Term Safety Study of Somavaratan in Japanese Children With Growth Hormone Deficiency
Somavaratan - Growth Hormone Deficiency
Phase 3TerminatedVersartis Inc.212017-03-312018-03-09
Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in Adult Growth Hormone Deficiency (AGHD)
somavaratan - Adult Growth Hormone Deficiency (AGHD)
Phase 2TerminatedVersartis Inc.362016-02-112023-04-13
Long-Acting Growth Hormone in Children Compared to Daily rhGH
Somavaratan, rhGH - Growth Disorders
Phase 3CompletedVersartis Inc.1382015-08-262022-12-30
Versartis Trial in Pre-pubertal Japanese Children With Growth Hormone Deficiency (GHD) to Assess Long-Acting Growth Hormone (Somavaratan, VRS-317)
Somavaratan (VRS-317) - Pediatric Growth Hormone Deficiency, Growth Disorders
Phase 2 / Phase 3TerminatedVersartis Inc.412015-08-082022-07-25
Versartis International Trial in Adults With Long-Acting Growth Hormone
somavaratan - Adult Growth Hormone Deficiency
Phase 2CompletedVersartis Inc.362015-07-012022-07-26
Versartis Long-Term Safety Study of Somavaratan
somavaratan - Pediatric Growth Hormone Deficiency
Phase 2 / Phase 3TerminatedVersartis Inc.3852014-03-032018-03-09
Versartis Trial in Children to Assess Long-Acting Growth Hormone
Experimental: VRS-317 - Pediatric Growth Hormone Deficiency
Phase 1 / Phase 2CompletedVersartis Inc.642012-10-012022-07-26
VRS-317 in Adult Subjects With Growth Hormone Deficiency
VRS-317 - Growth Hormone Deficiency
Phase 1CompletedVersartis Inc.502011-03-012012-07-23

Conditions studied

Dwarfism, Pituitary (7)  ·  Growth Disorders (3)  ·  Bone Diseases (1)  ·  Bone Diseases, Developmental (1)  ·  Bone Diseases, Endocrine (1)  ·  Brain Diseases (1)  ·  Dwarfism (1)  ·  Failure to Thrive (1)  ·  Hypopituitarism (1)  ·  Musculoskeletal Diseases (1)  ·  Pituitary Diseases (1)

Interventions

Growth Hormone-Releasing Hormone (1)  ·  Growth and Development (1)  ·  Hormone Replacement Therapy (1)  ·  Hormones (1)  ·  Hormones, Hormone Substitutes, and Hormone Antagonists (1)  ·  Insulin-Like Growth Factor Binding Protein 3 (1)  ·  Insulin-Like Growth Factor I (1)  ·  National Institute of Arthritis and Musculoskeletal and Skin Diseases (U.S.) (1)

Countries

United States (4)  ·  Australia (1)  ·  Germany (1)  ·  Japan (1)  ·  United Kingdom (1)

Top investigators

Will Charlton, MD (5)  ·  Daniela Rogoff, MD, PhD (1)  ·  Mark Kipnes, MD (1)

Results publications

PMID 23585663